Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2Zhihao Liu, Luoting Yu, Xi Hu et al.|Journal of Medicinal Chemistry|2021Cited by 116
YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defectQian Lei, Luoting Yu, Lu Xiong et al.|Cell Death and Disease|2018Cited by 65
Hepatitis B virus X protein (HBx) induces G2/M arrest and apoptosis through sustained activation of cyclin B1-CDK1 kinaseWei Wei|Oncology Reports|2009Cited by 51
Identification of novel 2-aminothiazole conjugated nitrofuran as antitubercular and antibacterial agentsKai Ran, Luoting Yu, Chao Gao et al.|Bioorganic & Medicinal Chemistry Letters|2016Cited by 39
Design and Synthesis of Fibroblast Growth Factor Receptor (FGFR) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of CancerGuoquan Wan, Luoting Yu, Zhanzhan Feng et al.|Journal of Medicinal Chemistry|2022Cited by 28